Physician profile
Heather Apling Rowell
NPI 1255041950
$925.62
in general payments reported to CMS, 2019-2025
18 companies · $906 in 2025
The $906 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.47 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $214.03 | 2025 | |
| Cequr Corporation | $100.00 | 2025 | Cequr Simplicity |
| Glaxosmithkline, LLC. | $97.11 | 2025 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.09 | 2025 | Jardiance |
| Axsome Therapeutics, INC. | $61.21 | 2025 | Sunosi, Auvelity |
| Lilly USA, LLC | $55.70 | 2025 | Mounjaro, Zepbound, Kisunla |
| Astrazeneca Pharmaceuticals LP | $48.42 | 2025 | Breztri, Airsupra |
| Philips North America LLC | $39.60 | 2025 | Extended Holter |
| Novo Nordisk INC | $36.06 | 2023-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $30.30 | 2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $29.15 | 2025 | Fanapt |
| Indivior INC. | $24.78 | 2025 | Sublocade |
| Verrica Pharmaceuticals INC. | $24.58 | 2025 | Ycanth |
| Daiichi Sankyo INC. | $23.75 | 2025 | Injectafer |
| Paratek Pharmaceuticals, INC. | $23.42 | 2025 | Nuzyra, Xhance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.58 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $17.07 | 2025 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.77 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.